Menú

GRenSSAP
GRenSSAP

Responsable del grupo
avatar_investigadors.jpg
Anna Berenguera Ossó
avatar_grups_recerca.png

Publicaciones

Corrigendum to «A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases» [Vaccine 42 (12) (2024) 3039-3048].

Schultze A, Martin I, Messina D, Bots S, Belitser S, Carreras-Martínez JJ, Correcher-Martinez E, Urchueguía-Fornes A, Martín-Pérez M, García-Poza P, Villalobos F, Pallejà-Millán M, Bissacco CA, Segundo E, Souverein P, Riefolo F, Durán CE, Gini R, Sturkenboom M, Klungel O and Douglas I
Vaccine. 2025 Jan 12; . doi:10.1016/j.vaccine.2024.126438; PMID:39396886

Ver más:
Incidence of severe and non-severe SARS-CoV-2 infections in children and adolescents: a population-based cohort study using six healthcare databases from Italy, Spain, and Norway.

Durán CE, Riefolo F, Gini R, Barbieri E, Messina D, Garcia P, Martin M, Villalobos F, Stona L, Carreras JJ, Urchueguía A, Correcher-Martínez E, Zhao J, Lupattelli A, Nordeng H and Sturkenboom M
EUROPEAN JOURNAL OF PEDIATRICS. 2024 Nov 13; . doi:10.1007/s00431-024-05864-1; PMID:39535547

Ver más:
Delivering an innovative multi-infection and female genital mutilation screening to high-risk migrant populations (ISMiHealth): study protocol of a cluster randomised controlled trial with embedded process evaluation

A. CRUZ, A. CUXART-GRAELL, A. GONCALVES, J. VAZQUEZ-VILLEGAS, S. VALLEJO-GODOY, J. SALAS-CORONAS, N. PIQUERAS, S. MARTINEZ-TORRES, E. ARTIGUES-BARBERA, Y. RANDO-MATOS, A. MARGALEJO, J. VIZCAINO, P. REQUENA, A. MARTINEZ-PEREZ, E. FERRER, L. MENDEZ-BOO, E. COMA, M. LUZON-GARCIA, E. SEQUEIRA-AYMAR, A. CASELLAS, M. VAZQUEZ, C. JACQUES-AVINO, L. MEDINA-PERUCHA, E. SICURI, S. EVANGELIDOU, C. AGUILAR MARTIN and A. REQUENA-MENDEZ
BMJ Open. 2024 Nov 4; . doi:10.1136/bmjopen-2023-078337; PMID:39496367

Ver más:
Safety of the Janssen COVID-19 vaccine (JCOVDEN) using VAC4EU European Healthcare Data Sources: Methods and Results of the Second Study Feasibility Assessment

F. AHMADIZAR, J. FORTUNY, A. ROYO, E. PLANA, R. WEINRIB, R. ESTEBAN, K. BORIC, N. YEFIMENKO, M. HAUGH, J. CARRERAS, A. URCHUEGUÍA-FORNES, E. CORRECHER, J. VAN DEN BERG, T. LYSEN, F. VILLALOBOS, C. BISSACCO, E. NEWBERN, C. WILLAME, N. PRAET and M. STURKENBOOM
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

Ver más:
Assessing the Impact of Data Diversity on Background Incidence Rates of Adverse Events of Special Interest: The Component Strategy from the COVID-19 Vaccine Monitoring Project

G. ROBERTO, D. MESSINA, C. DURÁN, J. RIERA-ARNAU, P. GARCIA, M. MARTÍN-PÉREZ, O. PAOLETTI, C. BISSACCO, F. VILLALOBOS, J. CARRERAS, A. MIRA, P. SOUVEREIN, F. RIEFOLO, O. KLUNGEL, M. STURKENBOOM and R. GINI
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

Ver más: